Companies/SE/EGTX

EGETIS THERAPEUTICS AB

Last · StockholmSEK 9.77-0.18 (-1.81%)stale · yahoo · 47h ago
Vol 255.6K ≈ 2.54M
Market capSEK 4.5B465.0M sh
P/E · TTM-9.9fwd 81.4 · eps -1.00 · loss
Beta0.78vs S&P 500
Div yield0.00%annual · TTM
52w range
SEK 3.625SEK 10.14
Volume221.3Ksession

Issuer

Legal nameEGETIS THERAPEUTICS AB
HQSweden (SE)
ListingSE EGTX
ISINSE0003815604
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyUSD
Entity registryisin:SE0003815604
Org IDEGTX
Websitewww.egetis.com
Employees44
AddressEgetis Therapeutics AB Klara Norra Kyrkogata 26 111 22, Stockholm +46 86 79 72 10
Loading chart…

Upcoming earnings

1 event
4:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.20
Est. revenue
24.9M
View upcoming earnings →

Press & signals

2 recent
  • GlobeNewswire

    Egetis Therapeutics Announces U.S. FDA Approval of EMCITATE® (tiratricol) for Patients with MCT8 Deficiency

  • GlobeNewswire

    Egetis Therapeutics to Participate in Upcoming Investor Conferences in September

Documents

FormReporting forFiledFlags
interim reportInterim Report Q2 2026IR
—2026-06-30≈0
interim reportInterim Report Q1 2026IR
—2026-03-31≈0
annual reportAnnual Report 2025IR
—2025-12-31≈0
financial tablesYear-end Report Q4 2025IR
—2025-12-31≈0
interim reportInterim Report Q3 2025IR
—2025-11-250
Showing 5 of 33 filings